Published Articles
Tunnell’s subject matter experts have written a number of informative pieces. Here are a sampling of articles that have been published in leading industry publications.
Harnessing Lab Deviations For Performance Transformation In Vaccine Manufacturing
Harnessing Lab Deviations For Performance Transformation In Vaccine Manufacturing
- September 2021
- Pharmaceutical Online
Bill Connell and Dave Stowe discuss the importance of de-risking sourcing
Bill Connell and Dave Stowe discuss the importance of de-risking sourcing
- August 2021
- Institute of Supply Management
How Emerging Life Sciences Companies Create Value With Suppliers
How Emerging Life Sciences Companies Create Value With Suppliers
- June 2021
- Pharmaceutical Commerce
Edgar Guerzon discusses how to ensure contract organizations are up to standard
Edgar Guerzon discusses how to ensure contract organizations are up to standard
- May 2021
- BioPharm
The Benefits Of Pharma 4.0 And Validation 4.0
The Benefits Of Pharma 4.0 And Validation 4.0
- June 1, 2021
- Life Science Leader
The Lasting Impact Of COVID-19 On Emerging Life Sciences Supply Chain
The Lasting Impact Of COVID-19 On Emerging Life Sciences Supply Chain
- June 1, 2021
- Life Science Leader
Are Your Suppliers Supporting Your Growth?
Are Your Suppliers Supporting Your Growth?
- May 2021
- Contract Pharma
The Art of Coaching and Mentoring in Life Sciences Manufacturing
The Art of Coaching and Mentoring in Life Sciences Manufacturing
- April 2021
- Life Science Leader
Jens Kuhn co-authors: Recent successes in therapeutics for Ebola virus disease: no time for complacency
Jens Kuhn co-authors: Recent successes in therapeutics for Ebola virus disease: no time for complacency
- June 2020
- The Lancet
Build CMO Relationships with Effective Management Practices
Build CMO Relationships with Effective Management Practices
- August 2020
- Pharmaceutical Technology
Contract service providers offer vital services to bio/pharma companies of all sizes
Advocates For AI In The Laggard Life Sciences
Advocates For AI In The Laggard Life Sciences
- August 2020
- BioProcess Online
Kip Wolf discusses how a lack of coordination and strategy could hamstring the value of AI investments